La Renon Healthcare
PrivateLast Round
Secondary
Nov 21, 2025
Est. Valuation
$1.2B
Total Funding Raised
$116M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
La Renon Healthcare is a pharmaceutical company that develops and manufactures branded chronic-therapy pharmaceutical formulations across various therapeutic segments including nephrology, neurology, critical care, and cardio-metabolic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
La Renon Healthcare Comparables
Compare La Renon Healthcare with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alniche Lifesciences Private Limited | 77% | |
| Renauxe Pharma India Private Limited | 77% | |
| Corona Remedies | 77% |
La Renon Healthcare Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Secondary | Nov 21, 2025 | ||||
| Secondary | Feb 4, 2025 | ||||
| Private Equity | Apr 16, 2024 | ||||
| Growth Equity | Jan 11, 2021 | ||||
| Series A | Jun 12, 2015 |
La Renon Healthcare Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ChrysCapital | Private Equity |
| A91 Partners | Growth Equity |
| Ashoka WhiteOak Capital | Secondary |
| Commelina Ltd. | Secondary |
| White Oak | Secondary |
| Avendus Capital | Secondary |
| Sequoia Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2026
Ranked among the top 50 pharmaceutical companies in India.
- Jun 5, 2026
Ranked among the top 25 pharma companies in India.
La Renon Healthcare Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about La Renon Healthcare's valuation, stock price, and market status.
Is La Renon a public or private company?
La Renon is a private company.
What is the current stock price of La Renon?
La Renon is a private company with no public stock price. No recent secondary market data is available.
How much is La Renon worth (valuation)?
La Renon's valuation is estimated at $1.3B based on funding round data.
Can I buy La Renon stock?
La Renon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was La Renon's last funding round?
La Renon's most recent funding round was Secondary on December 8, 2025.
Who are the main investors in La Renon?
Key investors in La Renon include A91 Partners, Commelina Ltd., Avendus Capital, Sequoia Capital.
Will La Renon IPO soon?
No public IPO plans have been announced for La Renon.
How can I track La Renon secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor La Renon's secondary market activity and sign up for updates.